Navigation Links
VCA fellowship funding to extend ovarian cancer research

Dr Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer.

Epithelial ovarian cancer, which is found in the cell lining (epithelium) of the ovary, accounts for 90 per cent of ovarian tumours. However, epithelial ovarian cancer is still poorly understood, and recent research has revealed that it may start in cells outside of the ovary.

Dr Scott is a laboratory head in the institute's Stem Cells and Cancer and Molecular Genetics of Cancer divisions and a medical oncologist at The Royal Melbourne Hospital. She said the VCA fellowship, worth $400,000 over two years, would help her to search for the origins of ovarian cancer.

"In addition to working out where ovarian cancer starts, we need more precise ways of studying human ovarian cancers in the laboratory and, with the VCA funding, we will work on improving those laboratory models," Dr Scott said.

"Because ovarian cancer becomes resistant to current therapies so often, it is essential that we discover new treatments. Being able to accurately study human ovarian cancers in animal models provides great advantages in this regard."

Dr Scott said the VCA funding would help to further fundamental research in the area, including the development of a more useful pre-clinical model for ovarian cancer than is currently available for testing new drugs.

Each year, more than 1200 Australian women are diagnosed with ovarian cancer, and around 800 will die from the disease. Ovarian cancer is the sixth major cause of cancer deaths in Australian women. Despite efforts to develop better screening tools, 80 per cent of epithelial ovarian cancers are diagnosed after they have spread beyond the ovary and 70 per cent are generally incurable.

Dr Scott is also the principal investigator in a program called, which receives funding from the Victorian Cancer Agency. is a web portal dedicated to coordinating patient information, research studies and clinical trials for rare cancers. Dr Scott will use this web portal to study rare ovarian cancers.

"The website provides a new way of linking patients into the system of research and clinical trials," Dr Scott said. "This increases the number of patients available for specialised research, with the ultimate goal of gathering enough entries over time to make clinical trials for different types of rare tumours a possibility."


Contact: Penny Fannin
Walter and Eliza Hall Institute

Related medicine news :

1. Fellowship allows diverse reporters to cultivate public awareness of aging issues
2. AWARD Fellowship highlights critical role of African women in agricultural research
3. Kennedy Krieger Institutes Dr. Paul Lipkin selected for national health policy fellowship
4. Outstanding high school students receive AGA Foundation 2010 Student Research Fellowship Awards
5. University of Toronto scholars receive prestigious New Directions Fellowships
6. Fellowship winners make cancer their focus
7. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
8. UCI stem cell researchers to receive $9.35 million in state funding
9. Hepatitis E research receives funding
10. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
11. UCI gets major funding to study ways of preventing drug-resistant staph infections
Post Your Comments:
Related Image:
VCA fellowship funding to extend ovarian cancer research
(Date:11/27/2015)... VVA (PRWEB) , ... November 27, 2015 , ... ... motto of progress through sharing, the 2016 Building Better Radiology Marketing ... The conference will begin on Sunday, March 6, 2016, at Caesars Palace in ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... ... 2015 , ... Keeping in mind challenges faced by parents ... consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for children ... and bring advice from parenting experts within their reach. As a part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Avid collector, Andrew ... Arbor Michigan boxing style concert posters. This is one of Joplin's most famous and ... House at the University of Michigan in Ann Arbor. The According to Hawley, "It ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: